{
    "clinical_study": {
        "@rank": "70388", 
        "arm_group": [
            {
                "arm_group_label": "Laparoscopic liver resection group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Open liver resection", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the clinical value of laparoscopic liver\n      resection in the treatment of hepatocellular carcinoma by assessing its Surgical and\n      oncologic outcomes comparing with open liver resection."
        }, 
        "brief_title": "Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma", 
        "completion_date": {
            "#text": "December 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Liver solid tumor, with clinical diagnosis of hepatocellular carcinoma\n\n          -  Located at segment \u2161\u3001\u2162\u3001\u2163b\u3001\u2164 or \u2165\n\n          -  The tumor location and size do not affect the dissection of hepatic hilar region\n\n          -  Tumor size less than 10cm\n\n          -  Without portal vein tumor thrombus\n\n          -  Without intrahepatic or distant metastasis\n\n          -  Willingness to participate in the study\n\n          -  Able to understand the nature of the study and what will be required of them\n\n          -  Body mass index of between 18 and 35\n\n          -  Child-Pugh classification of A to B\n\n          -  American Society of Anesthesiologists (ASA) grading of I to III\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating women\n\n          -  Unwillingness to participate\n\n          -  Inability to give written informed consent\n\n          -  Child-Pugh classification of C\n\n          -  ASA grading of IV to V\n\n          -  Tumor invasion of the inferior vena cava or confluence part of hepatic vein\n\n          -  Decompensated liver cirrhosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01768741", 
            "org_study_id": "SRRSH20121225-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laparoscopic liver resection group", 
                "description": "participants will be performed with laparoscopic hepatectomy using laparoscopic instruments", 
                "intervention_name": "Laparoscopic liver resection", 
                "intervention_type": "Procedure", 
                "other_name": "Laparoscopic hepatectomy"
            }, 
            {
                "arm_group_label": "Open liver resection", 
                "description": "participants will be performed with open hepatectomy using laparotomic instruments", 
                "intervention_name": "Open liver resection", 
                "intervention_type": "Procedure", 
                "other_name": "Open hepatectomy"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "hepatocellular carcinoma", 
        "lastchanged_date": "January 13, 2013", 
        "location": {
            "contact": {
                "email": "caixiujunzju@yahoo.com.cn", 
                "last_name": "Xiujun Cai, MD", 
                "phone": "0086-0571-86006605"
            }, 
            "contact_backup": {
                "email": "jason198508@126.com", 
                "last_name": "Renan Jin, MS", 
                "phone": "0086-0571-86006276"
            }, 
            "facility": {
                "address": {
                    "city": "Hangzhou", 
                    "country": "China", 
                    "state": "Zhejiang", 
                    "zip": "310000"
                }, 
                "name": "Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Trial of Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma", 
        "other_outcome": {
            "measure": "Hospital costs", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 9 days"
        }, 
        "overall_contact": {
            "email": "caixiujunzju@yahoo.com.cn", 
            "last_name": "Xiujun Cai, MD", 
            "phone": "0086-0571-86006605"
        }, 
        "overall_official": {
            "affiliation": "Sir Run Run Shaw Hospital", 
            "last_name": "Xiujun Cai, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Total survival time and disease free survival time", 
            "safety_issue": "No", 
            "time_frame": "up to 5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01768741"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sir Run Run Shaw Hospital", 
            "investigator_full_name": "Xiujun Cai", 
            "investigator_title": "Executive Vice-President", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Surgical margins", 
                "safety_issue": "Yes", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Time to functional recovery", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 6 days"
            }, 
            {
                "measure": "Postoperative hospital stay", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 7 days"
            }, 
            {
                "measure": "Morbidity and mortality", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 months"
            }, 
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "up to 1 year"
            }, 
            {
                "measure": "Intraoperative parameters including operation time,pneumoperitoneum time, liver resection time, estimated blood loss,transfusion, as well as number,size and location of the tumor", 
                "safety_issue": "Yes", 
                "time_frame": "participants will be followed for the duration of operation, an expected average of 90 min"
            }, 
            {
                "description": "Regulatory T cells and associated cytokines in peripheral blood will be tested 1day before operation,5 days, 3,6 months and 1,3,5 years after operation", 
                "measure": "Regulatory T cells and associated cytokines in peripheral blood", 
                "safety_issue": "No", 
                "time_frame": "up to 5 years"
            }, 
            {
                "measure": "Regulatory T cells and associated cytokines in liver cancer\u3001para-carcinoma and healthy liver tissue", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Sir Run Run Shaw Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sir Run Run Shaw Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}